Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET-Reference-Cited by-同舟云学术

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET

Published:2022-07 Issue: Volume:Volume 17 Page:1703-1713
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Alter Peter^ORCID,Kahnert Kathrin,Trudzinski Franziska C^ORCID,Bals Robert,Watz Henrik,Speicher Tim,Söhler Sandra^ORCID,Andreas Stefan^ORCID,Welte Tobias^ORCID,Rabe Klaus F^ORCID,Wouters Emiel FM,Sassmann-Schweda Antonia,Wirtz Hubert,Ficker Joachim H^ORCID,Vogelmeier Claus F,Jörres Rudolf A^ORCID

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference16 articles.

1. Clusters of Comorbidities Based on Validated Objective Measurements and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease

Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort

3. The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline

4. Update in Chronic Obstructive Pulmonary Disease 2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modifiable risk factors that may be addressed in routine care to prevent progression to and extension of multimorbidity in people with COPD: a systematic literature review;BMJ Open Respiratory Research;2024-04

2. Promising Intestinal Microbiota Associated with Clinical Characteristics of COPD Through Integrated Bioinformatics Analysis;International Journal of Chronic Obstructive Pulmonary Disease;2024-04

3. Association between chronic obstructive pulmonary disease and in-hospital mortality after percutaneous coronary intervention: a retrospective cohort study in Germany;Scientific Reports;2024-03-13

4. Designing inhaled small molecule drugs for severe respiratory diseases: an overview of the challenges and opportunities;Expert Opinion on Drug Discovery;2024-02-26

5. New markers in chronic obstructive pulmonary disease;Advances in Clinical Chemistry;2024